Advertisement
Screener

Aerie Pharmaceuticals, Inc. Research and Development Expense

Aerie Pharmaceuticals, Inc. Research and Development Expense

Aerie Pharmaceuticals, Inc. reported Research and Development Expense of $21.99 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2022-11-04

  • Aerie Pharmaceuticals, Inc. research and development expense for the quarter ending 2022-09-30 was $21.99M, a 14.96% increase year-over-year.
  • Aerie Pharmaceuticals, Inc. research and development expense for the quarter ending 2022-06-30 was $19.56M, a 8.86% increase year-over-year.
  • Aerie Pharmaceuticals, Inc. research and development expense for the quarter ending 2022-03-31 was $25.17M, a 40.71% increase year-over-year.
  • Aerie Pharmaceuticals, Inc. research and development expense for the quarter ending 2021-12-31 was $20.85M, a 11.33% increase year-over-year.
  • Aerie Pharmaceuticals, Inc. research and development expense for fiscal 2021 was $75.84M, a 2.47% increase from fiscal 2020.
  • Aerie Pharmaceuticals, Inc. research and development expense for fiscal 2020 was $74.01M, a 19.01% decline from fiscal 2019.
  • Aerie Pharmaceuticals, Inc. research and development expense for fiscal 2019 was $91.38M, a 6.10% increase from fiscal 2018.
  • Aerie Pharmaceuticals, Inc. research and development expense for fiscal 2018 was $86.12M, a 19.49% increase from fiscal 2017.
Period endResearch and Development ExpenseResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 monthResearch and Development Expense 99 monthResearch and Development Expense 102 monthResearch and Development Expense 105 monthResearch and Development Expense 108 monthResearch and Development Expense 111 month
2022-09-30$21.99M
10-Q · filed 2022-11-04
$41.55M
derived: sum of 2 quarters · filed 2022-11-04
$66.73M
10-Q · filed 2022-11-04
$87.57M
derived: sum of 4 quarters · filed 2022-11-04
2022-06-30$19.56M
10-Q · filed 2022-08-05
$44.73M
10-Q · filed 2022-08-05
$65.58M
derived: sum of 3 quarters · filed 2022-08-05
$84.71M
derived: sum of 4 quarters · filed 2022-11-04
2022-03-31$25.17M
10-Q · filed 2022-05-06
$46.02M
derived: sum of 2 quarters · filed 2022-05-06
$65.15M
derived: sum of 3 quarters · filed 2022-11-04
$83.12M
derived: sum of 4 quarters · filed 2022-11-04
2021-12-31$20.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$39.98M
derived: sum of 2 quarters · filed 2022-11-04
$57.95M
derived: sum of 3 quarters · filed 2022-11-04
$75.84M
10-K · filed 2022-02-25
2021-09-30$19.13M
10-Q · filed 2022-11-04
$37.10M
derived: sum of 2 quarters · filed 2022-11-04
$54.99M
10-Q · filed 2022-11-04
$73.72M
derived: sum of 4 quarters · filed 2022-11-04
2021-06-30$17.97M
10-Q · filed 2022-08-05
$35.86M
10-Q · filed 2022-08-05
$54.58M
derived: sum of 3 quarters · filed 2022-08-05
$70.75M
derived: sum of 4 quarters · filed 2022-08-05
2021-03-31$17.89M
10-Q · filed 2022-05-06
$36.62M
derived: sum of 2 quarters · filed 2022-05-06
$52.78M
derived: sum of 3 quarters · filed 2022-05-06
$72.72M
derived: sum of 4 quarters · filed 2022-05-06
2020-12-31$18.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$34.89M
derived: sum of 2 quarters · filed 2022-02-25
$54.83M
derived: sum of 3 quarters · filed 2022-02-25
$74.01M
10-K · filed 2022-02-25
2020-09-30$16.16M
10-Q · filed 2021-11-05
$36.11M
derived: sum of 2 quarters · filed 2021-11-05
$55.28M
10-Q · filed 2021-11-05
$86.08M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$19.94M
10-Q · filed 2021-08-05
$39.12M
10-Q · filed 2021-08-05
$69.91M
derived: sum of 3 quarters · filed 2022-02-25
$91.71M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$19.17M
10-Q · filed 2021-05-06
$49.97M
derived: sum of 2 quarters · filed 2022-02-25
$71.76M
derived: sum of 3 quarters · filed 2022-02-25
$92.67M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$30.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$52.59M
derived: sum of 2 quarters · filed 2022-02-25
$73.49M
derived: sum of 3 quarters · filed 2022-02-25
$91.38M
10-K · filed 2022-02-25
2019-09-30$21.80M
10-Q · filed 2020-11-06
$42.70M
derived: sum of 2 quarters · filed 2020-11-06
$60.58M
10-Q · filed 2020-11-06
$87.08M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$20.90M
10-Q · filed 2020-08-07
$38.79M
10-Q · filed 2020-08-07
$65.28M
derived: sum of 3 quarters · filed 2021-02-26
$93.78M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$17.88M
10-Q · filed 2020-05-07
$44.38M
derived: sum of 2 quarters · filed 2021-02-26
$72.88M
derived: sum of 3 quarters · filed 2021-02-26
$91.03M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$26.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$54.99M
derived: sum of 2 quarters · filed 2021-02-26
$73.15M
derived: sum of 3 quarters · filed 2021-02-26
$86.12M
10-K · filed 2021-02-26
2018-09-30$28.50M
10-Q · filed 2019-11-07
$46.66M
derived: sum of 2 quarters · filed 2019-11-07
$59.63M
10-Q · filed 2019-11-07
$97.73M
derived: sum of 4 quarters · filed 2020-02-24
2018-06-30$18.16M
10-Q · filed 2019-08-08
$31.13M
10-Q · filed 2019-08-08
$69.23M
derived: sum of 3 quarters · filed 2020-02-24
$81.64M
derived: sum of 4 quarters · filed 2020-02-24
2018-03-31$12.97M
10-Q · filed 2019-05-08
$51.07M
derived: sum of 2 quarters · filed 2020-02-24
$63.48M
derived: sum of 3 quarters · filed 2020-02-24
$74.10M
derived: sum of 4 quarters · filed 2020-02-24
2017-12-31$38.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24
$50.51M
derived: sum of 2 quarters · filed 2020-02-24
$61.12M
derived: sum of 3 quarters · filed 2020-02-24
$72.08M
10-K · filed 2020-02-24
2017-10-04$24.80M
10-K · filed 2018-03-01
2017-09-30$12.41M
10-Q · filed 2018-11-07
$23.02M
derived: sum of 2 quarters · filed 2018-11-07
$33.98M
10-Q · filed 2018-11-07
$48.07M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$10.62M
10-Q · filed 2018-08-09
$21.57M
10-Q · filed 2018-08-09
$35.66M
derived: sum of 3 quarters · filed 2019-03-01
$48.35M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$10.95M
10-Q · filed 2018-05-09
$25.05M
derived: sum of 2 quarters · filed 2019-03-01
$37.73M
derived: sum of 3 quarters · filed 2019-03-01
$51.04M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31$14.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$26.78M
derived: sum of 2 quarters · filed 2019-03-01
$40.09M
derived: sum of 3 quarters · filed 2019-03-01
$52.39M
10-K · filed 2019-03-01
2016-09-30$12.69M
10-Q · filed 2017-11-09
$25.99M
derived: sum of 2 quarters · filed 2017-11-09
$38.30M
10-Q · filed 2017-11-09
$50.60M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30$13.30M
10-Q · filed 2017-08-03
$25.61M
10-Q · filed 2017-08-03
$37.91M
derived: sum of 3 quarters · filed 2018-03-01
$47.82M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$12.31M
10-Q · filed 2017-05-03
$24.61M
derived: sum of 2 quarters · filed 2018-03-01
$34.52M
derived: sum of 3 quarters · filed 2018-03-01
$45.14M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$12.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$22.21M
derived: sum of 2 quarters · filed 2018-03-01
$32.83M
derived: sum of 3 quarters · filed 2018-03-01
$44.45M
10-K · filed 2018-03-01
2015-09-30$9.90M
10-Q · filed 2016-11-03
$20.53M
derived: sum of 2 quarters · filed 2016-11-03
$32.15M
10-Q · filed 2016-11-03
$41.74M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$10.63M
10-Q · filed 2016-08-04
$22.25M
10-Q · filed 2016-08-04
$31.84M
derived: sum of 3 quarters · filed 2017-03-09
$40.07M
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31$11.62M
10-Q · filed 2016-05-03
$21.21M
derived: sum of 2 quarters · filed 2017-03-09
$29.44M
derived: sum of 3 quarters · filed 2017-03-09
$36.12M
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31$9.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
$17.82M
derived: sum of 2 quarters · filed 2017-03-09
$24.50M
derived: sum of 3 quarters · filed 2017-03-09
$29.87M
10-K · filed 2017-03-09
2014-09-30$8.23M
10-Q · filed 2015-11-06
$14.91M
derived: sum of 2 quarters · filed 2015-11-06
$20.28M
10-Q · filed 2015-11-06
$23.43M
derived: sum of 4 quarters · filed 2016-03-02
$75.31M
10-Q · filed 2014-11-12
2014-06-30$6.68M
10-Q · filed 2015-08-06
$12.05M
10-Q · filed 2015-08-06
$15.20M
derived: sum of 3 quarters · filed 2016-03-02
$17.60M
derived: sum of 4 quarters · filed 2016-03-02
$67.08M
10-Q · filed 2014-08-07
2014-03-31$5.37M
10-Q · filed 2015-05-08
$8.53M
derived: sum of 2 quarters · filed 2016-03-02
$10.93M
derived: sum of 3 quarters · filed 2016-03-02
$14.10M
derived: sum of 4 quarters · filed 2016-03-02
$60.40M
10-Q · filed 2014-05-13
2013-12-31$3.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-02
$5.55M
derived: sum of 2 quarters · filed 2016-03-02
$8.73M
derived: sum of 3 quarters · filed 2016-03-02
$11.88M
10-K · filed 2016-03-02
$55.03M
10-K · filed 2014-03-26
2013-09-30$2.40M
10-Q · filed 2014-11-12
$5.57M
derived: sum of 2 quarters · filed 2014-11-12
$8.73M
10-Q · filed 2014-11-12
$10.70M
derived: sum of 4 quarters · filed 2015-02-27
$51.88M
10-Q · filed 2013-12-05
2013-06-30$3.17M
10-Q · filed 2014-08-07
$6.33M
10-Q · filed 2014-08-07
$8.30M
derived: sum of 3 quarters · filed 2015-02-27
$9.67M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$3.15M
10-Q · filed 2014-05-13
$5.12M
derived: sum of 2 quarters · filed 2015-02-27
$6.50M
derived: sum of 3 quarters · filed 2015-02-27
2012-12-31$1.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$3.34M
derived: sum of 2 quarters · filed 2015-02-27
$9.27M
10-K · filed 2015-02-27
2012-09-30$1.37M
10-Q · filed 2013-12-05
$7.30M
10-Q · filed 2013-12-05
2011-12-31$10.70M
10-K · filed 2014-03-26